NFAT1 mediates placental growth factor-induced myelomonocytic cell recruitment via the induction of TNF-α

Journal of Immunology

Volumn 184, Issue 5, 2010, Pages 2593-2601

  Ding, Yanping ^a   Huang, Yujie ^a   Song, Nan ^a   Gao, Xiaobin ^a   Yuan, Shaopeng ^a   Wang, Xiaofeng ^a   Cai, Hongchen ^a   Fu, Yan ^a   Luo, Yongzhang ^a  

^a TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; PLACENTAL GROWTH FACTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFAT1; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA ANTIBODY; UNCLASSIFIED DRUG; VASCULOTROPIN RECEPTOR 1; CYCLOSPORIN; OLIGOPEPTIDE; PLACENTA PROTEIN; TRANSCRIPTION FACTOR NFAT; VIVIT PEPTIDE;

ACUTE MYELOMONOCYTIC LEUKEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE RELEASE; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; INFLAMMATION; LEUKEMIA CELL; MOLECULAR DYNAMICS; MOUSE; MYELOMONOCYTIC CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN TARGETING; RNA INTERFERENCE; TUMOR MODEL; UPREGULATION; ANIMAL; BONE MARROW CELL; C57BL MOUSE; CELL LINE; CELL MOTION; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; EXPERIMENTAL NEOPLASM; FLUORESCENT ANTIBODY TECHNIQUE; GENETIC TRANSFECTION; GENETICS; IMMUNOBLOTTING; METABOLISM; MONOCYTE; PATHOLOGY; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; CELL LINE; CELL LINE, TUMOR; CELL MOVEMENT; CYCLOSPORINE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; MICE; MICE, INBRED C57BL; MONOCYTES; MYELOID CELLS; NEOPLASMS, EXPERIMENTAL; NFATC TRANSCRIPTION FACTORS; OLIGOPEPTIDES; PREGNANCY PROTEINS; RNA INTERFERENCE; TRANSFECTION; TRANSPLANTATION, HETEROLOGOUS; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1;

EID: 77951920351     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0902378     Document Type: Article

References (53)

1. Colombo, M. P., and A. Mantovani. 2005. Targeting myelomonocytic cells to revert inflammation-dependent cancer promotion. Cancer Res. 65: 9113-9116.
2. Lewis, C. E., and J. W. Pollard. 2006. Distinct role of macrophages in different tumor microenvironments. Cancer Res. 66: 605-612. (Pubitemid 43165918)
3. Greaves, D. R., and T. J. Schall. 2000. Chemokines and myeloid cell recruitment. Microbes Infect. 2: 331-336.
4. Murdoch, C., A. Giannoudis, and C. E. Lewis. 2004. Mechanisms regulating the recruitment of macrophages into hypoxic areas of tumors and other ischemic tissues. Blood 104: 2224-2234.
5. Schmid, M. C., and J. A. Varner. 2007. Myeloid cell trafficking and tumor angiogenesis. Cancer Lett. 250: 1-8.
6. Murdoch, C., M. Muthana, S. B. Coffelt, and C. E. Lewis. 2008. The role of myeloid cells in the promotion of tumour angiogenesis. Nat. Rev. Cancer 8: 618-631.
7. Kaplan, R. N., R. D. Riba, S. Zacharoulis, A. H. Bramley, L. Vincent, C. Costa, D. D. MacDonald, D. K. Jin, K. Shido, S. A. Kerns, et al. 2005. VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438: 820-827.
8. Pollard, J. W. 2004. Tumour-educated macrophages promote tumour progression and metastasis. Nat. Rev. Cancer 4: 71-78.
9. Clauss, M., H. Weich, G. Breier, U. Knies, W. Röckl, J. Waltenberger, and W. Risau. 1996. The vascular endothelial growth factor receptor Flt-1 mediates biological activities. Implications for a functional role of placenta growth factor in monocyte activation and chemotaxis. J. Biol. Chem. 271: 17629-17634.
10. Adini, A., T. Kornaga, F. Firoozbakht, and L. E. Benjamin. 2002. Placental growth factor is a survival factor for tumor endothelial cells and macrophages. Cancer Res. 62: 2749-2752.
11. Ribatti, D. 2008. The discovery of the placental growth factor and its role in angiogenesis: a historical review. Angiogenesis 11: 215-221.
12. 164/165 and PlGF: roles in angiogenesis and arteriogenesis. Trends Cardiovasc. Med. 13: 169-175.
13. Tjwa, M., A. Luttun, M. Autiero, and P. Carmeliet. 2003. VEGF and PlGF: two pleiotropic growth factors with distinct roles in development and homeostasis. Cell Tissue Res. 314: 5-14. (Pubitemid 37409908)
14. Luttun, A., M. Autiero, M. Tjwa, and P. Carmeliet. 2004. Genetic dissection of tumor angiogenesis: are PlGF and VEGFR-1 novel anti-cancer targets? Biochim. Biophys. Acta 1654: 79-94.
15. Fischer, C., B. Jonckx, M. Mazzone, S. Zacchigna, S. Loges, L. Pattarini, E. Chorianopoulos, L. Liesenborghs, M. Koch, M. De Mol, et al. 2007. Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131: 463-475.
16. Fischer, C., M. Mazzone, B. Jonckx, and P. Carmeliet. 2008. FLT1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy? Nat. Rev. Cancer 8: 942-956.
17. Selvaraj, S. K., R. K. Giri, N. Perelman, C. Johnson, P. Malik, and V. K. Kalra. 2003. Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor. Blood 102: 1515-1524.
18. Tchaikovski, V., G. Fellbrich, and J. Waltenberger. 2008. The molecular basis of VEGFR-1 signal transduction pathways in primary human monocytes. Arterioscler. Thromb. Vasc. Biol. 28: 322-328.
19. Shaw, J. P., P. J. Utz, D. B. Durand, J. J. Toole, E. A. Emmel, and G. R. Crabtree. 1988. Identification of a putative regulator of early T cell activation genes. Science 241: 202-205.
20. Hogan, P. G., L. Chen, J. Nardone, and A. Rao. 2003. Transcriptional regulation by calcium, calcineurin, and NFAT. Genes Dev. 17: 2205-2232.
21. 2+/calcineurin signalling in cells of the immune system. Biochem. Biophys. Res. Commun. 311: 1117-1132.
22. Lopez-Rodriguez, C., J. Aramburu, A. S. Rakeman, N. G. Copeland, D. J. Gilbert, S. Thomas, C. Disteche, N. A. Jenkins, and A. Rao. 1999. NF-AT5: the NF-AT family of transcription factors expands in a new direction. Cold Spring Harb. Symp. Quant. Biol. 64: 517-526.
23. Rao, A., C. Luo, and P. G. Hogan. 1997. Transcription factors of the NFAT family: regulation and function. Annu. Rev. Immunol. 15: 707-747.
24. 2+/calcineurin-NFAT-mediated signaling. Mol. Cells 18: 1-9.
25. Beals, C. R., C. M. Sheridan, C. W. Turck, P. Gardner, and G. R. Crabtree. 1997. Nuclear export of NF-ATc enhanced by glycogen synthase kinase-3. Science 275: 1930-1934.
26. Graef, I. A., P. G. Mermelstein, K. Stankunas, J. R. Neilson, K. Deisseroth, R. W. Tsien, and G. R. Crabtree. 1999. L-type calcium channels and GSK-3 regulate the activity of NF-ATc4 in hippocampal neurons. Nature 401: 703-708.
27. Vyas, D. R., E. E. Spangenburg, T. W. Abraha, T. E. Childs, and F. W. Booth. 2002. GSK-3b negatively regulates skeletal myotube hypertrophy. Am. J. Physiol. Cell Physiol. 283: C545-C551.
28. Yiu, G. K., and A. Toker. 2006. NFAT induces breast cancer cell invasion by promoting the induction of cyclooxygenase-2. J. Biol. Chem. 281: 12210-12217.
29. Duque, J., M. Fresno, and M. A. Iñiguez. 2005. Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2. J. Biol. Chem. 280: 8686-8693.
30. Liu, Z., N. Dronadula, and G. N. Rao. 2004. A novel role for nuclear factor of activated T cells in receptor tyrosine kinase and G protein-coupled receptor agonist-induced vascular smooth muscle cell motility. J. Biol. Chem. 279: 41218-41226.
31. Balkwill, F. 2006. TNF-α in promotion and progression of cancer. Cancer Metastasis Rev. 25: 409-416.
32. Balkwill, F. 2002. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 13: 135-141.
33. Bradley, J. R. 2008. TNF-mediated inflammatory disease. J. Pathol. 214: 149-160.
34. -) bone marrow cells. J. Immunol. 177: 100-108.
35. Shi, H. B., Y. J. Huang, H. Zhou, X. M. Song, S. P. Yuan, Y. Fu, and Y. Z. Luo. 2007. Nucleolin is a receptor that mediates antiangiogenic and antitumor activity of endostatin. Blood 110: 2899-2906.
36. Chen, Q., Y. Zhao, Z. Cheng, Y. Xu, and C. Yu. 2008. Establishment of a cell-based assay for examining the expression of tumor necrosis factor alpha (TNF-α) gene. Appl. Microbiol. Biotechnol. 80: 357-363.
37. Yuan, S. P., Y. Fu, X. F. Wang, H. B. Shi, Y. J. Huang, X. M. Song, L. Li, N. Song, and Y. Z. Luo. 2008. Voltage-dependent anion channel 1 is involved in endostatin-induced endothelial cell apoptosis. FASEB J. 22: 2809-2820.
38. Huang, Y., H. Shi, H. Zhou, X. Song, S. Yuan, and Y. Luo. 2006. The angiogenic function of nucleolin is mediated by vascular endothelial growth factor and nonmuscle myosin. Blood 107: 3564-3571.
39. Kuriyama, M., M. Matsushita, A. Tateishi, A. Moriwaki, K. Tomizawa, K. Ishino, S. Sano, and H. Matsui. 2006. A cell-permeable NFAT inhibitor peptide prevents pressure-overload cardiac hypertrophy. Chem. Biol. Drug Des. 67: 238-243.
40. McCaffrey, P. G., A. E. Goldfeld, and A. Rao. 1994. The role of NFATp in cyclosporin A-sensitive tumor necrosis factor-a gene transcription. J. Biol. Chem. 269: 30445-30450.
41. Cianfarani, F., G. Zambruno, L. Brogelli, F. Sera, P. M. Lacal, M. Pesce, M. C. Capogrossi, C. M. Failla, M. Napolitano, and T. Odorisio. 2006. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am. J. Pathol. 169: 1167-1182.
42. Khurana, R., L. Moons, S. Shafi, A. Luttun, D. Collen, J. F. Martin, P. Carmeliet, and I. C. Zachary. 2005. Placental growth factor promotes atherosclerotic intimal thickening and macrophage accumulation. Circulation 111: 2828-2836. (Pubitemid 40791556)
43. Kerber, M., Y. Reiss, A. Wickersheim, M. Jugold, F. Kiessling, M. Heil, V. Tchaikovski, J. Waltenberger, M. Shibuya, K. H. Plate, and M. R. Machein. 2008. Flt-1 signaling in macrophages promotes glioma growth in vivo. Cancer Res. 68: 7342-7351.
44. Zaichuk, T. A., E. H. Shroff, R. Emmanuel, S. Filleur, T. Nelius, and O. V. Volpert. 2004. Nuclear factor of activated T cells balances angiogenesis activation and inhibition. J. Exp. Med. 199: 1513-1522.
45. Armesilla, A. L., E. Lorenzo, P. Gómez del Arco, S. Martínez-Martínez, A. Alfranca, and J. M. Redondo. 1999. Vascular endothelial growth factor activates nuclear factor of activated T cells in human endothelial cells: a role for tissue factor gene expression. Mol. Cell. Biol. 19: 2032-2043.
46. Hernández, G. L., O. V. Volpert, M. A. Iñiguez, E. Lorenzo, S. Martínez-Martínez, R. Grau, M. Fresno, and J. M. Redondo. 2001. Selective inhibition of vascular endothelial growth factor-mediated angiogenesis by cyclosporin A: roles of the nuclear factor of activated T cells and cyclooxygenase 2. J. Exp. Med. 193: 607-620.
47. Christinger, H. W., G. Fuh, A. M. de Vos, and C. Wiesmann. 2004. The crystal structure of placental growth factor in complex with domain 2 of vascular endothelial growth factor receptor-1. J. Biol. Chem. 279: 10382-10388.
48. Kitaura, J., K. Asai, M. Maeda-Yamamoto, Y. Kawakami, U. Kikkawa, and T. Kawakami. 2000. Akt-dependent cytokine production in mast cells. J. Exp. Med. 192: 729-740.
49. Goldfeld, A. E., P. G. McCaffrey, J. L. Strominger, and A. Rao. 1993. Identification of a novel cyclosporin-sensitive element in the human tumor necrosis factor a gene promoter. J. Exp. Med. 178: 1365-1379.
50. Kaminuma, O., F. Kitamura, N. Kitamura, T. Hiroi, H. Miyoshi, A. Miyawaki, and S. Miyatake. 2008. Differential contribution of NFATc2 and NFATc1 to TNF-a gene expression in T cells. J. Immunol. 180: 319-326.
51. Nguyen, J., J. Gogusev, P. Knapnougel, and B. Bauvois. 2006. Protein tyrosine kinase and p38 MAP kinase pathways are involved in stimulation of matrix metalloproteinase-9 by TNF-α in human monocytes. Immunol. Lett. 106: 34-41.
52. Burger, D., and J. M. Dayer. 2002. Cytokines, acute-phase proteins, and hormones: IL-1 and TNF-a production in contact-mediated activation of monocytes by T lymphocytes. Ann. N. Y. Acad. Sci. 966: 464-473.
53. Kuang, D. M., Q. Zhao, C. Peng, J. Xu, J. P. Zhang, C. Wu, and L. M. Zheng. 2009. Activated monocytes in peritumoral stroma of hepatocellular carcinoma foster immune privilege and disease progression through PD-L1. J. Exp. Med. 206: 1327-1337.